↓ Skip to main content

Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
1 X user
patent
8 patents
googleplus
1 Google+ user

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
110 Mendeley
Title
Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers
Published in
Drug Safety, November 2012
DOI 10.2165/11534570-000000000-00000
Pubmed ID
Authors

DrNikolaos Papanas, Efstratios Maltezos

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Singapore 1 <1%
Belgium 1 <1%
Unknown 108 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 17%
Student > Master 11 10%
Student > Bachelor 11 10%
Student > Doctoral Student 10 9%
Other 9 8%
Other 24 22%
Unknown 26 24%
Readers by discipline Count As %
Medicine and Dentistry 29 26%
Agricultural and Biological Sciences 16 15%
Biochemistry, Genetics and Molecular Biology 7 6%
Engineering 5 5%
Nursing and Health Professions 4 4%
Other 21 19%
Unknown 28 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#4,369,647
of 25,374,647 outputs
Outputs from Drug Safety
#468
of 1,852 outputs
Outputs of similar age
#41,207
of 285,367 outputs
Outputs of similar age from Drug Safety
#181
of 812 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.